Commemorate
发表于 2025-3-25 03:55:41
Gastroesophageal Reflux Disease: Preoperative Evaluation,and endoscopic findings have low accuracy, leading to a wrong diagnosis in up to 30 % of patients. As a consequence, many patients without GERD are often treated with expensive medications or are referred for antireflux surgery on the assumption that symptoms are caused by reflux..Since the proper s
WAX
发表于 2025-3-25 10:08:45
http://reply.papertrans.cn/89/8826/882539/882539_22.png
tooth-decay
发表于 2025-3-25 12:39:25
http://reply.papertrans.cn/89/8826/882539/882539_23.png
移动
发表于 2025-3-25 16:31:29
http://reply.papertrans.cn/89/8826/882539/882539_24.png
无能性
发表于 2025-3-25 23:36:00
http://reply.papertrans.cn/89/8826/882539/882539_25.png
巨大没有
发表于 2025-3-26 00:50:47
Endoscopic Management of Achalasia,hat absent peristalsis means that there is no progressively sequenced esophageal contraction; it does not imply the complete absence of esophageal contractions or intraluminal pressure. In fact, spastic contractions and panesophageal pressurization of the esophagus are often seen in patients with ac
Terrace
发表于 2025-3-26 05:07:55
Surgical Treatment of Esophageal Achalasia,rtial fundoplication is considered in most centers the standard of care, while pneumatic dilatation is mainly reserved for the management of patients unfit for surgery or in case of surgical failure. Recently, the peroral endoscopic myotomy (POEM) has been proposed as a new approach to achalasia.
串通
发表于 2025-3-26 09:46:50
http://reply.papertrans.cn/89/8826/882539/882539_28.png
火光在摇曳
发表于 2025-3-26 13:11:38
Minimally Invasive Treatment of Benign Esophageal Tumors,2; Attah EB, Hajdu SI, J Thorac Cardiovasc Surg 55(3):396–404, 1968) and only 1–2 % of resected esophageal neoplasms (Nguyen NT, Reavis KM, El-Badawi K, Hinojosa MW, Smith BR, Surg Innov 15(2):120–125, 2008). Most of them are clinically unremarkable. Thus, expectant management of a small, benign-app
休战
发表于 2025-3-26 17:03:45
,Barrett’s Esophagus: Treatment Options and Management,omized trials have demonstrated mortality benefit, we recommend patients with multiple risk factors for BE undergo endoscopic screening for dysplasia (which should be confirmed by an expert pathologist). Patients with BE should be treated with proton pump inhibitor (PPI) and be considered for PPI ev